Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2023.105833DOI Listing

Publication Analysis

Top Keywords

novel gnal
4
gnal pathogenic
4
pathogenic variant
4
variant leading
4
leading generalized
4
generalized dystonia
4
dystonia sustained
4
sustained response
4
response globus
4
globus pallidus
4

Similar Publications

Article Synopsis
  • Dystonia is a common movement disorder with a complex genetic background, showing significant variability in its clinical presentation and genetics.
  • The study involved exome sequencing of nearly 1,924 patients, mainly from two major registries, focusing on those with genetic prescreening negative results and early age at onset.
  • Researchers discovered 137 likely pathogenic variants in 51 genes among the patients, with many being novel, highlighting the challenges in diagnosing and understanding the disorder's genetic links.
View Article and Find Full Text PDF

Background: Cell death modulates the biological behaviors of tumors. However, the comprehensive role of the multiple forms of cell death in lower-grade glioma (LGG) is unknown.

Methods: We collected the transcriptional data of LGG patients from public repositories to comprehensively examine six cell death patterns (autophagy, apoptosis, cuproptosis, necroptosis, ferroptosis, and pyroptosis) in LGG samples and systematically correlated these patterns with patient survival, underlying biological processes, and drug sensitivity using serial bioinformatics analysis, clinical sample validation and assays.

View Article and Find Full Text PDF
Article Synopsis
  • Loss-of-function mutations in a specific gene linked to dystonia reveal similarities to idiopathic dystonia, highlighting the gene's role in regulating cAMP levels in the striatum, a brain region critical for movement.
  • Researchers developed a genetic mouse model to study the effects of knocking out this gene in a targeted manner, observing significant motor impairments and dystonic behaviors in these mice.
  • The findings indicate that the loss of this gene increases the excitability of certain neurons, suggesting that reducing this hyperexcitability could lead to potential treatments for both genetic and idiopathic forms of dystonia.
View Article and Find Full Text PDF
Article Synopsis
  • Primary and secondary adrenal insufficiency (AI) can occur as immune-related side effects from immune checkpoint inhibitors (ICIs), making it crucial to identify at-risk patients for better safety management.
  • * Recent studies have focused on finding new biomarkers, particularly autoantibodies, that may indicate susceptibility to ICI-induced AI through T-cell activation of autoreactive B cells.
  • * The review discusses various autoantibodies linked to primary and secondary AI and suggests that standardized testing for these autoantibodies could help in identifying patients at risk, ultimately improving the treatment and management of ICI-induced AI.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!